Highly sensitive chemiluminescence immunoassay for benzo[a]pyrene-DNA adducts:: validation by comparison with other methods, and use in human biomonitoring

被引:65
作者
Divi, RL
Beland, FA
Fu, PP
Von Tungeln, LS
Schoket, B
Camara, JE
Ghei, M
Rothman, N
Sinha, R
Poirier, MC
机构
[1] NCI, Carcinogen DNA Interact Sect, NIH, Bethesda, MD 20892 USA
[2] Natl Ctr Toxicol Res, Jefferson, AR 72079 USA
[3] Jozef Fordor Natl Ctr Publ Hlth, H-1097 Budapest, Hungary
关键词
D O I
10.1093/carcin/23.12.2043
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A chemiluminescence immunoassay (CIA) utilizing antiserum elicited against DNA modified with (+/-)-7beta, 8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]- pyrene (BPDE) has been developed and validated to study the formation of polycyclic aromatic hydrocarbon (PAH)-DNA adducts in human tissues. Advantages include a low limit of detection for 10b-(deoxyguanosin-N-2-yl)-7beta,8alpha,9alpha-trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene (BPdG, similar to1.5 adducts/10(9) nucleotides using 20 mug DNA) and a high signal-to-noise ratio (greater than or equal to100). The CIA BPDE-DNA standard curve gave 50% inhibition at 0.60 +/- 0.08 fmol BPdG (mean +/- SE, n = 30), which was a 10-fold increase in sensitivity compared with the dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA). Calf thymus DNA modified with [1,3-H-3]BPDE was assayed by radiolabeling, P-32-postlabeling, DELFIA and CIA, and all assays gave similar values. Liver DNAs from mice exposed to 0.5 and 1.0 mg [7,8-H-3]benzo[a]pyrene (BP) were assayed by the same four assays and a dose-response was obtained with all assays. The BPDE-DNA CIA was further validated in MCL-5 cells exposed to 4 muM BP for 24 h, where nuclear and mitochondrial DNA adduct levels were associated with an increase in DNA tail length measured by the Comet assay. Human peripheral blood cell (buffy coat) DNA samples (n = 43) obtained from 25 individuals who were either colorectal adenocarcinoma patients or controls were assayed by BPDE-DNA CIA. Three samples (7%) were non-detectable, and the remaining 40 samples had values between 0.71 and 2.21 PAH-DNA adducts/10(8) nucleotides. The intra-assay coefficient of variation (CV), for four wells on the same microtiter plate, was 1.85%. Sufficient DNA for two assays, on separate plates, was available for 38 of the 43 samples, and the PAH-DNA adduct values obtained were highly correlated (r(2) = 0.95). Coded duplicate DNA samples from 15 individuals were assayed four times gave an inter-assay CV of 13.8%.
引用
收藏
页码:2043 / 2049
页数:7
相关论文
共 41 条
[1]  
ANDERSON MW, 1981, CANCER RES, V41, P4309
[2]  
ASHURST SW, 1983, CANCER RES, V43, P1024
[3]   The use of benzo[a]pyrene diolepoxide-modified DNA standards for adduct quantification in P-32-postlabelling to assess exposure to polycyclic aromatic hydrocarbons: application in a biomonitoring study [J].
Baan, RA ;
Steenwinkel, MJST ;
vanAsten, S ;
Roggeband, R ;
vanDelft, JHM .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1997, 378 (1-2) :41-50
[4]   MITOCHONDRIAL-DNA IS A MAJOR CELLULAR TARGET FOR A DIHYDRODIOL-EPOXIDE DERIVATIVE OF BENZO[A]PYRENE [J].
BACKER, JM ;
WEINSTEIN, IB .
SCIENCE, 1980, 209 (4453) :297-299
[5]   HYBRIDIZATION OF NUCLEAR MATRIX ATTACHED DEOXYRIBONUCLEIC-ACID FRAGMENTS [J].
BASLER, J ;
HASTIE, ND ;
PIETRAS, D ;
MATSUI, SI ;
SANDBERG, AA ;
BEREZNEY, R .
BIOCHEMISTRY, 1981, 20 (24) :6921-6929
[6]   Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard [J].
Beland, FA ;
Doerge, DR ;
Churchwell, MI ;
Poirier, MC ;
Schoket, B ;
Marques, MM .
CHEMICAL RESEARCH IN TOXICOLOGY, 1999, 12 (01) :68-77
[7]   RAPID ISOLATION, HYDROLYSIS AND CHROMATOGRAPHY OF FORMALDEHYDE-MODIFIED DNA [J].
BELAND, FA ;
FULLERTON, NF ;
HEFLICH, RH .
JOURNAL OF CHROMATOGRAPHY, 1984, 308 (JUN) :121-131
[8]   MUTAGENICITY OF BENZO[A]PYRENE AND DIBENZOPYRENES IN THE SALMONELLA-TYPHIMURIUM TM677 AND THE MCL-5 HUMAN CELL FORWARD MUTATION ASSAYS [J].
BUSBY, WF ;
SMITH, H ;
CRESPI, CL ;
PENMAN, BW .
MUTATION RESEARCH-GENETIC TOXICOLOGY, 1995, 342 (1-2) :9-16
[9]   A METABOLICALLY COMPETENT HUMAN CELL-LINE EXPRESSING 5 CDNAS ENCODING PROCARCINOGEN-ACTIVATING ENZYMES - APPLICATION TO MUTAGENICITY TESTING [J].
CRESPI, CL ;
GONZALEZ, FJ ;
STEIMEL, DT ;
TURNER, TR ;
GELBOIN, HV ;
PENMAN, BW ;
LANGENBACH, R .
CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (05) :566-572
[10]   DNA adduct measurements, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar or benzo[a]pyrene [J].
Culp, SJ ;
Warbritton, AR ;
Smith, BA ;
Li, EE ;
Beland, FA .
CARCINOGENESIS, 2000, 21 (07) :1433-1440